Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type

2017/03/09 by Sung Hoon Sim, Soyeon Kim, Tae Min Kim +10 · 25 citations
Medicine · #Lymphoma Diagnosis and Treatment #Mycobacterium research and diagnosis #Cytokine Signaling Pathways and Interactions

paper · pdf · doi:10.1016/j.ajpath.2017.01.004

Cited by

• Current treatment approaches for NK/T-cell lymphoma. [europepmc]
• The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation. [europepmc]
• Prognostic and therapeutic significance of phosphorylated STAT3 and protein tyrosine phosphatase-6 in peripheral-T cell lymphoma. [europepmc]
• Advances in multiple omics of natural-killer/T cell lymphoma. [europepmc]
• Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders. [europepmc]
• Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL). [europepmc]
• Molecular pathogenic pathways in extranodal NK/T cell lymphoma. [europepmc]
• JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/T‑cell lymphoma, nasal type. [europepmc]
• Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma. [europepmc]
• Phosphorylated STAT3 expression predicts better prognosis in smoldering type of adult T-cell leukemia/lymphoma. [europepmc]
• Somatic mutations in KMT2D and TET2 associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders. [europepmc]
• An Enteropathy-like Indolent NK-Cell Proliferation Presenting in the Female Genital Tract. [europepmc]
• Identification of Two Kinase Inhibitors with Synergistic Toxicity with Low-Dose Hydrogen Peroxide in Colorectal Cancer Cells in vitro. [europepmc]
• Biology and Molecular Pathogenesis of Mature T-Cell Lymphomas. [europepmc]
• Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma in Asia Frequently Shows SETD2 Alterations. [europepmc]
• Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma. [europepmc]
• Selection of new immunotherapy targets for NK/T cell lymphoma. [europepmc]
• EBV and the Pathogenesis of NK/T Cell Lymphoma. [europepmc]
• Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors-A Strategy for Hematological Malignancies? [europepmc]
• The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer. [europepmc]
• The Pathologic and Genetic Characteristics of Extranodal NK/T-Cell Lymphoma. [europepmc]
• Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions. [europepmc]
• Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer/T-cell lymphoma. [europepmc]
• Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma. [europepmc]
• Novel target and treatment agents for natural killer/T-cell lymphoma. [europepmc]